Home
/
ESCALON MEDICAL CORP
/
Financials
/
Quarterly
ESCALON MEDICAL CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ESCALON MEDICAL CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Mar 31, 2024
$2.70M
May 14, 2024
Q2
2024
Dec 31, 2023
$2.87M
Feb 14, 2024
Q1
2025
Sep 30, 2023
$2.95M
Nov 14, 2024
Q3
2024
Mar 31, 2023
$3.43M
May 14, 2024
Q2
2024
Dec 31, 2022
$3.01M
Feb 14, 2024
Q1
2024
Sep 30, 2022
$2.60M
Nov 17, 2023
Q3
2023
Mar 31, 2022
$2.42M
May 15, 2023
Q2
2023
Dec 31, 2021
$2.70M
Feb 14, 2023
Q1
2023
Sep 30, 2021
$2.68M
Nov 14, 2022
Q3
2022
Mar 31, 2021
$2.32M
May 13, 2022
Q2
2022
Dec 31, 2020
$2.90M
Feb 14, 2022
Q3
2020
Mar 31, 2020
$2.36M
May 14, 2020
Q2
2020
Dec 31, 2019
$2.74M
Feb 14, 2020
Q3
2020
Mar 31, 2019
$2.67M
May 14, 2020
Q2
2020
Dec 31, 2018
$2.42M
Feb 14, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Mar 31, 2025
$3.47M
May 14, 2025
Q2
2025
Dec 31, 2024
$3.22M
Feb 14, 2025
Q3
2025
Mar 31, 2024
$2.70M
May 14, 2025
Q2
2025
Dec 31, 2023
$2.87M
Feb 14, 2025
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Mar 31, 2019
$2.67M
May 14, 2019
Q2
2019
Dec 31, 2018
$2.42M
Feb 14, 2019
Q1
2019
Sep 30, 2018
$2.26M
Nov 14, 2018
Q3
2019
Mar 31, 2018
$2.64M
May 14, 2019
Q2
2019
Dec 31, 2017
$3.38M
Feb 14, 2019
Q1
2019
Sep 30, 2017
$2.63M
Nov 14, 2018
Q3
2018
Mar 31, 2017
$2.85M
May 14, 2018
Q2
2018
Dec 31, 2016
$3.16M
Feb 14, 2018
Q1
2018
Sep 30, 2016
$2.33M
Nov 14, 2017
Q3
2017
Mar 31, 2016
$3.10M
May 15, 2017
Q2
2017
Dec 31, 2015
$2.99M
Feb 14, 2017
Q1
2017
Sep 30, 2015
$2.78M
Nov 18, 2016
Q3
2016
Mar 31, 2015
$3.43M
May 16, 2016
Q2
2016
Dec 31, 2014
$3.70M
Feb 16, 2016
Q1
2016
Sep 30, 2014
$2.63M
Nov 16, 2015
Q3
2015
Mar 31, 2014
$3.15M
May 14, 2015
Q2
2015
Dec 31, 2013
$3.08M
Feb 13, 2015
Q1
2014
Sep 30, 2013
$3.13M
Nov 14, 2014
Q3
2014
Mar 31, 2013
$2.72M
May 14, 2014
Q2
2014
Dec 31, 2012
$3.64M
Feb 14, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$97.7K
Feb 17, 2026
Q1
2026
Sep 30, 2025
($239.9K)
Nov 14, 2025
Q2
2026
Sep 30, 2025
($239.9K)
Feb 17, 2026
Q3
2025
Mar 31, 2025
$271.5K
May 14, 2025
Q2
2026
Dec 31, 2024
$246.0K
Feb 17, 2026
Q3
2025
Dec 31, 2024
$246.0K
May 14, 2025
Q1
2026
Sep 30, 2024
($32.2K)
Nov 14, 2025
Q2
2026
Sep 30, 2024
($32.2K)
Feb 17, 2026
Q3
2025
Sep 30, 2024
($32.2K)
May 14, 2025
Q3
2025
Mar 31, 2024
($162.1K)
May 14, 2025
Q2
2025
Dec 31, 2023
($76.3K)
Feb 14, 2025
Q3
2025
Dec 31, 2023
($76.3K)
May 14, 2025
Q2
2025
Sep 30, 2023
($21.2K)
Feb 14, 2025
Q1
2025
Sep 30, 2023
($21.2K)
Nov 14, 2024
Q3
2025
Sep 30, 2023
($21.2K)
May 14, 2025
Q3
2024
Mar 31, 2023
$585.2K
May 14, 2024
Q1
2024
Mar 31, 2023
($21.2K)
Nov 17, 2023
Q3
2024
Dec 31, 2022
($6.0K)
May 14, 2024
Q2
2024
Dec 31, 2022
($6.0K)
Feb 14, 2024
Q1
2024
Sep 30, 2022
($320.7K)
Nov 17, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$98.7K
Feb 17, 2026
Q1
2026
Sep 30, 2025
($202.8K)
Nov 14, 2025
Q3
2025
Mar 31, 2025
$276.0K
May 14, 2025
Q2
2026
Dec 31, 2024
$255.9K
Feb 17, 2026
Q1
2026
Sep 30, 2024
($27.0K)
Nov 14, 2025
Q3
2025
Mar 31, 2024
($156.6K)
May 14, 2025
Q2
2025
Dec 31, 2023
($70.5K)
Feb 14, 2025
Q1
2025
Sep 30, 2023
($15.6K)
Nov 14, 2024
Q3
2024
Mar 31, 2023
$589.6K
May 14, 2024
Q2
2024
Dec 31, 2022
$3
Feb 14, 2024
Q1
2024
Sep 30, 2022
($315.9K)
Nov 17, 2023
Q3
2023
Mar 31, 2022
($291.9K)
May 15, 2023
Q2
2023
Dec 31, 2021
($49.1K)
Feb 14, 2023
Q1
2023
Sep 30, 2021
($184.5K)
Nov 14, 2022
Q3
2022
Mar 31, 2021
($132.2K)
May 13, 2022
Q2
2022
Dec 31, 2020
$103.8K
Feb 14, 2022
Q1
2022
Sep 30, 2020
($191.6K)
Nov 15, 2021
Q3
2021
Mar 31, 2020
($128.3K)
May 14, 2021
Q2
2021
Dec 31, 2019
($673.0K)
Feb 16, 2021
Q1
2021
Sep 30, 2019
($133.7K)
Nov 16, 2020